In an interview on CNBC’s Mad Money, Kevin Sayer said continuous glucose monitoring has made people healthier and safer. He noted that when customers use GLP-1’s in combination with CGMs, their results are much better. Dexcom is gaining market share both in the U.S. and abroad, he added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DXCM: